Review




Structured Review

Takeda oras by dominant-negative otulin mutant
Oras By Dominant Negative Otulin Mutant, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oras+by+dominant-negative+otulin+mutant/oras+by+dominant+negative+otulin+mutant/pm38652464-235-12-0
Average 90 stars, based on 1 article reviews
oras by dominant-negative otulin mutant - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Dominant Negative Mutation:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Mutagenesis:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Ubiquitin Proteomics:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Activity Assay:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Activation Assay:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Control:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Variant Assay:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Staining:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Purification:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).

Binding Assay:

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S2 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Figure S3.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 15 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine S6 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 13 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 patient.

Article Title: A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome.
Article Snippet: Takeda et al. Journal of Experimental Medicine 11 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 D ow nloaded from http://rupress.org/jem /article-pdf/221/6/e20231941/1927461/jem _20231941.pdf by guest on 01 M ay 2024 Takeda et al. Journal of Experimental Medicine 12 of 20 ORAS by dominant-negative OTULIN mutant https://doi.org/10.1084/jem.20231941 OTULIN WT were as sensitive to TNF-mediated cell death (a characteristic feature of ORAS) as the original patient-derived MSCs (Fig. 6, F–J).



Similar Products

90
Takeda oras by dominant-negative otulin mutant
Oras By Dominant Negative Otulin Mutant, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oras+by+dominant-negative+otulin+mutant/oras+by+dominant+negative+otulin+mutant/pm38652464-235-12-0
Average 90 stars, based on 1 article reviews
oras by dominant-negative otulin mutant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results